Proxima Bio
New York, US · Delaware corporation · 1 known investors
Founders & leadership
JM
John McFarlandExecutive
ZC
Zachary CarpenterNamed on SEC filing
Board
JP
AG
Alex GasnerBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$91.5M disclosed across 1 round · 2026
▶$91.5MraisedJun 2026 · 11 investors · Other Health CareRule 506(b)
▶$91.5MraisedJun 2026 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason PontinDirector
- Zachary CarpenterExecutive Officer, Director
- Alex GasnerDirector
- John McFarlandExecutive Officer
- Offering amount
- $91.5M
- Amount sold
- $91.5M
- Minimum investment
- $1
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Proxima Bio's investors?
- Proxima Bio's investors include DCVC (Data Collective).
- How much funding has Proxima Bio raised?
- Proxima Bio has disclosed $91.5M raised across 1 round.
- Where is Proxima Bio headquartered?
- Proxima Bio is headquartered in New York, US.